NASDAQ:VERO - Nasdaq - US92332W3034 - Common Stock - Currency: USD
Overall VERO gets a fundamental rating of 1 out of 10. We evaluated VERO against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VERO have multiple concerns. VERO has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -78.1% | ||
ROE | -2191.2% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 67.9% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 9.53 | ||
Debt/FCF | N/A | ||
Altman-Z | -7.41 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.28 | ||
Quick Ratio | 0.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
2.3
+0.02 (+0.88%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.05 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.44 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -78.1% | ||
ROE | -2191.2% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 67.9% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 9.53 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 3.44% | ||
Cap/Sales | 0.22% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.28 | ||
Quick Ratio | 0.79 | ||
Altman-Z | -7.41 |